While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Novo Nordisk has disclosed recent transactions involving the purchase of 1,300 American Depositary Receipts (ADRs) by its board members and executives. This move, involving a total value of DKK ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

For further insights into NVO stock, check out TipRanks’ Stock Analysis page. Trending Articles Novo Nordisk NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

Amgen Inc.‘s AMGN stock dropped over 7% on Tuesday following revelations ... MariTide, positioned as a monthly alternative to ...

Leerink upgrades Bristol-Myers Squibb with an increased price target and strong sales projections for Cobenfy and milvexian, ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

Novo Nordisk is working on a new obesity drug that could help patients ... The team has an Overweight rating on Novo stock ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...